Increasing Primary Care Physician Colorectal Cancer Screening Rates

NCT ID: NCT00955344

Last Updated: 2016-08-17

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 134 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2009-09-30
• Study Completion Date: 2011-11-30

Brief Summary

The purpose of the study is to determine if a Web-based intervention increases physician rates of colorectal cancer recommendation rates in a group of physicians participating in the American Board of Internal Medicine's Maintenance of Certification Program. This study will also compare the content of practice improvement plans submitted by the diplomats in each study arm to determine the components of the plans that are associated with colorectal cancer rates.

Detailed Description

Colorectal cancer is the 2nd leading cause of cancer deaths in the U.S. Although colorectal cancer screening (CRCS) is effective, cost-effective and consistently recommended by clinical practice guidelines, only 57.3% of the adults over 50 years have been screened within the recommended interval. Preliminary research conducted by this PI demonstrates that approximately 90% of patients who have not had CRCS report that a doctors recommendation would motivate them to undergo screening. However, research also shows that physicians do not consistently recommend CRCS to each eligible patient. In this study the barriers of and facilitators to physician recommendation of CRCS are tested in the to proposed randomized controlled trial. The trial will pilot test an interactive, multifaceted, Web-based intervention (eToolbox) to increase primary care physician rates of CRCS. This application innovatively proposes to pilot test the eToolbox in the setting of the American Board of Internal Medicine (ABIM) Maintenance of Certification process within the Preventive Services Practice Improvement Module, a physician-directed measurement of their performance and quality improvement requirement for board re-certification.

Conditions

Colorectal Cancer Screening

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: PREVENTION
• Blinding Strategy: NONE

Study Groups

Web-based intervention (eToolbox)

This arm will allow diplomats of the American Board of Internal Medicine to complete the Practice Improvement Module that will embed a link to the web-based intervention (eToolbox).

Group Type: EXPERIMENTAL

eToolbox

Intervention Type: BEHAVIORAL

Participants randomized to the Web-based intervention will be automatically routed to a URL that will contain the Web-based intervention.

Practice Improvement Module

This arm will allow diplomats of the American Board of Internal Medicine to complete the Practice Improvement Module without any link to the Web-based eToolbox.

Group Type: ACTIVE_COMPARATOR

no link to eToolbox

Intervention Type: BEHAVIORAL

Participants randomized to the Practice Improvement Module will not be automatically routed to a URL that will contain the Web-based intervention.

Interventions

eToolbox

Participants randomized to the Web-based intervention will be automatically routed to a URL that will contain the Web-based intervention.

Intervention Type: BEHAVIORAL

no link to eToolbox

Participants randomized to the Practice Improvement Module will not be automatically routed to a URL that will contain the Web-based intervention.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• ABIM certification and have or plan to enroll in the Maintenance of Certification program
• Primary Care Physicians

Exclusion Criteria

• Diplomats are not able to participate in this study if they are retired physicians, do not practice a primary care practice or who have already taken part in the study

• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

National Cancer Institute (NCI)

NIH

Sponsor Role: collaborator

National Institutes of Health (NIH)

NIH

Sponsor Role: collaborator

Department of Health and Human Services

FED

Sponsor Role: collaborator

University of Pennsylvania

OTHER

Sponsor Role: lead

Responsible Party

Universirty of Pennsylvania School of Medicine

Principal Investigators

Carmen E Guerra, MD

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

Locations

University of Pennsylvania School of Medicine

Philadelphia, Pennsylvania, United States

Countries

United States

Other Identifiers

K22CA133186-01

Identifier Type: NIH

Identifier Source: org_study_id

View Link